Why the study?
Does specific treatment affect the persistence of EVI antibodies in patients with Chagas' disease?
Does specific treatment affect the persistence of EVI antibodies in patients with Chagas' disease?
EVI antibodies persist after Chagas' disease cure and are primarily induced by heart structure antigens, suggesting they do not play a role in controlling T. cruzi infection.
No takes yet. Share an insight, caveat, or question.
EVI antibodies should not indicate active infection or prompt retreatment in cured Chagas patients; leaves open their contribution to cardiac autoimmunity.
Brener et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: